Share this:

CERN Supported Research Shared at SNO

CERN Supported Research Shows Improvements in Patient Care and Outcomes 

Since its founding in 2006, the CERN Foundation has been committed to improving the care and outcome of people with ependymoma through community support and research efforts. Today, we are excited to share that our support of research and patient and caregiver participation in the research have made a significant impact.

The key findings of the research studies, which focus on the role of chemotherapy for recurrent ependymoma and genetic and environmental risk factors among adult ependymoma patients, were presented at the 2018 Annual Meeting of the Society for Neuro-Oncology (SNO), held November 15 to 18, 2018, in New Orleans. The meeting had a record attendance of 2,400 registrants and CERN was honored to be among them. A synopsis of the research findings shared at SNO is provided in this summary.
Thank you, immensely, patients, caregivers and families, for your participation over the past 13 years. It is you who have made these findings possible.

Dr. Terri Armstrong
The CERN Foundation is focused on understanding outcomes for patients with ependymoma and hope to use this information to improve patient care. 

Miracle Boy Sharing Hope

By Gina (Ian's Mom)

CERN Inspiration Story
In May of 2009, when Ian was 15-months-old, he was rushed to emergency surgery. The cause – an anaplastic ependymoma brain tumor. He had a very low chance of surviving and his parents were told to prepare for the worst. After a scary surgery, he began 19 months of successful treatment and was declared cancer free.
Now, at age 11, this miracle boy is sharing hope to the world and to those battling ependymoma that need an inspiration.

Follow us.
Friend us.
Follow us.
CERN Foundation PO Box 217 | Zionsville, IN 46077 US
powered by emma
Subscribe to our email list.